ArticleBritish journal of haematology2014

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia.

Aneel Paulus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.